For: | Monaco S, Mariotto S, Ferrari S, Calabrese M, Zanusso G, Gajofatto A, Sansonno D, Dammacco F. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J Gastroenterol 2015; 21(42): 11974-11983 [PMID: 26576086 DOI: 10.3748/wjg.v21.i42.11974] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v21/i42/11974.htm |
Number | Citing Articles |
1 |
Waleed Ezzat Madboly, Magdi G. Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief. Using power of calculated electrons to cut, analyze and exterminate the outer and the inner biological elements of hepatitis C virus without blood parameters disorders: In vitro study: low potential codified ions for hepatitis therapy. Asian Journal of Applied Science and Engineering 2022; 11(1): 45 doi: 10.18034/ajase.v11i1.16
|
2 |
Daniel M. Forton. Hepatitis C – the brain strain. Liver International 2016; 36(10): 1415 doi: 10.1111/liv.13162
|
3 |
Donna M. Evon, Paul W. Stewart, Jipcy Amador, Marina Serper, Anna S. Lok, Richard K. Sterling, Souvik Sarkar, Carol E. Golin, Bryce B. Reeve, David R. Nelson, Nancy Reau, Joseph K. Lim, K. Rajender Reddy, Adrian M. Di Bisceglie, Michael W. Fried, Chen-Hua Liu. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLOS ONE 2018; 13(8): e0196908 doi: 10.1371/journal.pone.0196908
|
4 |
Jennifer M. Loftis, Juno Valerio, Jonathan Taylor, Elaine Huang, Rebekah Hudson, Patricia Taylor‐Young, Michael Chang, Samuel B. Ho, Eric Dieperink, Juan Luis Miranda, Peter Hauser. S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood–Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcoholism: Clinical and Experimental Research 2018; 42(8): 1466 doi: 10.1111/acer.13796
|
5 |
Dario Roccatello, David Saadoun, Manuel Ramos-Casals, Athanasios G. Tzioufas, Fernando C. Fervenza, Patrice Cacoub, Anna Linda Zignego, Clodoveo Ferri. Cryoglobulinaemia. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/s41572-018-0009-4
|
6 |
Franco Dammacco, Patrice Cacoub, John H. Stone, David Saadoun. A Clinician's Pearls & Myths in Rheumatology. 2023; : 395 doi: 10.1007/978-3-031-23488-0_25
|
7 |
Daniel Scharfenberg, Ann-Katrin Schild, Clemens Warnke, Franziska Maier. A network perspective on neuropsychiatric and cognitive symptoms of the post-COVID syndrome. Europe’s Journal of Psychology 2022; 18(4): 350 doi: 10.5964/ejop.10097
|
8 |
T. Morozova, I. Chernikov, T. Peretolchina. Characteristics of cerebral hemodynamics in patients with chronic HBV- and HCV-associated hepatitis. Vrach 2024; 34(4): 59 doi: 10.29296/25877305-2023-04-12
|
9 |
Zahra Amirsardari, Farzaneh Rahmani, Nima Rezaei. Cognitive impairments in HCV infection: From pathogenesis to neuroimaging. Journal of Clinical and Experimental Neuropsychology 2019; 41(10): 987 doi: 10.1080/13803395.2019.1652728
|
10 |
Simone Corgiolu, Luigi Barberini, Jasjit S. Suri, Antonella Mandas, Diego Costaggiu, Paola Piano, Fulvio Zaccagna, Pierleone Lucatelli, Antonella Balestrieri, Luca Saba. Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study. European Journal of Radiology 2018; 102: 220 doi: 10.1016/j.ejrad.2018.03.022
|
11 |
Gloria Vaghi, Benedetta Gori, Gionata Strigaro, Michela Burlone, Rosalba Minisini, Matteo N. Barbaglia, Elena Brigatti, Claudia Varrasi, Mario Pirisi, Roberto Cantello. Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study. Journal of NeuroVirology 2020; 26(6): 870 doi: 10.1007/s13365-020-00904-6
|
12 |
A. E. Geraskin, L. M. Mosina, L. V. Chegodaeva. Cryoglobulinemic vasculitis as an extrahepatic manifestation of HCV infec- tion. Clinical Medicine (Russian Journal) 2021; 98(9-10): 709 doi: 10.30629/0023-2149-2020-98-9-10-709-712
|
13 |
Stelliana Goutzamanis, Joseph Doyle, Peter Higgs, Margaret Hellard. Improving hepatitis C direct‐acting antiviral access and uptake: A role for patient‐reported outcomes and lived experience. Journal of Viral Hepatitis 2019; 26(2): 218 doi: 10.1111/jvh.13020
|
14 |
Andrea Marino, Daniele Scuderi, Maria Elena Locatelli, Adele Gentile, Alessio Pampaloni, Federica Cosentino, Manuela Ceccarelli, Benedetto Maurizio Celesia, Francesco Benanti, Giuseppe Nunnari, Arturo Montineri, Bruno Cacopardo. Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders. Hepatitis Monthly 2020; 20(2) doi: 10.5812/hepatmon.95101
|
15 |
Sérgio M. de Almeida. Encyclopedia of Infection and Immunity. 2022; : 302 doi: 10.1016/B978-0-12-818731-9.00123-3
|
16 |
Tatsuki Ichikawa, Hisamitsu Miyaaki, Satoshi Miuma, Naota Taura, Yasuhide Motoyoshi, Hiroshi Akahoshi, Satomi Nakamura, Junpei Nakamura, Youichi Takahashi, Tetsurou Honda, Hiroyuki Yajima, Ryouhei Uehara, Naoyuki Hino, Syouhei Narita, Hisaya Tanaka, Seina Sasaki, Kazuhiko Nakao. Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12974
|
17 |
David Pires Barreira, Rui Tato Marinho, Manuel Bicho, Isabel Flores, Renata Fialho, Sílvia Ouakinin. Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects. Frontiers in Psychology 2019; 10 doi: 10.3389/fpsyg.2019.02317
|
18 |
Doaa Salah Hegab, Mohammed Abd El Rahman Sweilam. Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection. Dermatology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/182609
|
19 |
Soledad Retamozo, Pilar Brito-Zerón, Luca Quartuccio, Salvatore De Vita, Manuel Ramos-Casals. Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection. Expert Review of Clinical Pharmacology 2017; 10(10): 1085 doi: 10.1080/17512433.2017.1357466
|
20 |
Ali A. Weinstein, J. Michael Estep, Leyla de Avila, Michael Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Jillian K. Price, Lynn Gerber, Zobair M. Younossi. Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study. Journal of Neuroimmunology 2019; 335: 577022 doi: 10.1016/j.jneuroim.2019.577022
|
21 |
Sarah L. Martindale, Robin A. Hurley, Katherine H. Taber. Neurobiology and Neuroimaging of Chronic Hepatitis C Virus: Implications for Neuropsychiatry. The Journal of Neuropsychiatry and Clinical Neurosciences 2017; 29(4): A6 doi: 10.1176/appi.neuropsych.17080163
|
22 |
Franco Dammacco, Sabino Russi, Domenico Sansonno. Systemic Vasculitides: Current Status and Perspectives. 2016; : 333 doi: 10.1007/978-3-319-40136-2_29
|
23 |
Silvia Squarza, Alberto Galli, Maurizio Cariati, Federico Alberici, Valentina Bertolini, Fabio Frediani, Carla Uggetti. Magnetic resonance imaging in central nervous system vasculitis in a patient affected by crioglobulin-negative hepatitis C virus infection: A likely correlation. The Neuroradiology Journal 2018; 31(2): 193 doi: 10.1177/1971400917700437
|
24 |
Karn Wijarnpreecha, Supavit Chesdachai, Veeravich Jaruvongvanich, Patompong Ungprasert. Hepatitis C virus infection and risk of Parkinson’s disease: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(1): 9 doi: 10.1097/MEG.0000000000000991
|
25 |
Franco Dammacco, Gianfranco Lauletta, Sabino Russi, Patrizia Leone, Marco Tucci, Carlo Manno, Salvatore Monaco, Sergio Ferrari, Angelo Vacca, Vito Racanelli. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clinical and Experimental Medicine 2019; 19(1): 1 doi: 10.1007/s10238-018-0536-z
|
26 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_94-1
|
27 |
Pegah Golabi, Munkhzul Otgonsuren, Mehmet Sayiner, Aimal Arsalla, Trevor Gogoll, Zobair M. Younossi. The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection. Annals of Hepatology 2017; 16(3): 342 doi: 10.5604/01.3001.0009.8588
|
28 |
A. Calcagno, G. Di Perri, S. Bonora. Treating HIV Infection in the Central Nervous System. Drugs 2017; 77(2): 145 doi: 10.1007/s40265-016-0678-9
|
29 |
Tatiana Lins Carvalho, Alessandra Cintia Mertens Brainer de Queiroz Lima, Noemi Salazar de Araújo, Matheus Santos de Sousa Fernandes, Gabriela Barza Lira, Marcela Maria Medeiros de Melo, Luydson Richardson Silva Vasconcelos, Patrícia Muniz Mendes Freire de Moura, Carolina da Cunha Correia. Aspects of cognitive assessments and spectroscopic magnetic resonance imaging in people with chronic hepatitis C: a systematic review. Psychology, Health & Medicine 2023; 28(4): 1013 doi: 10.1080/13548506.2022.2029915
|
30 |
Ameer Abutaleb, Sarah Kattakuzhy, Shyam Kottilil, Erin O’Connor, Eleanor Wilson. Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns. Journal of NeuroVirology 2018; 24(6): 670 doi: 10.1007/s13365-018-0678-5
|
31 |
Tatyana Polukchi, Zulfiya Zhankalova, Gulzhan Abuova, Akhmedova Muborakhon. Quality of life assessment in chronic viral hepatitis. Journal of Clinical Medicine of Kazakhstan 2022; 19(3): 19 doi: 10.23950/jcmk/12149
|
32 |
Luciana Besedovsky, Tanja Lange, Monika Haack. The Sleep-Immune Crosstalk in Health and Disease. Physiological Reviews 2019; 99(3): 1325 doi: 10.1152/physrev.00010.2018
|
33 |
Zhongsheng Peng, Michael R. Duggan, Heather E. Dark, Gulzar N. Daya, Yang An, Christos Davatzikos, Guray Erus, Alexandria Lewis, Abhay R. Moghekar, Keenan A. Walker. Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers. Neurobiology of Aging 2022; 120: 34 doi: 10.1016/j.neurobiolaging.2022.08.004
|
34 |
David Pires Barreira, Rui Tato Marinho, Manuel Bicho, Renata Fialho, Silvia Raquel Soares Ouakinin. Psychosocial and Neurocognitive Factors Associated With Hepatitis C – Implications for Future Health and Wellbeing. Frontiers in Psychology 2019; 9 doi: 10.3389/fpsyg.2018.02666
|
35 |
Herng-Ching Lin, Sudha Xirasagar, Hsin-Chien Lee, Chung-Chien Huang, Chao-Hung Chen, Yury E Khudyakov. Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder. PLOS ONE 2017; 12(6): e0179312 doi: 10.1371/journal.pone.0179312
|
36 |
Chiara Formentin, Maria Garrido, Sara Montagnese. Assessment and Management of Sleep Disturbance in Cirrhosis. Current Hepatology Reports 2018; 17(1): 52 doi: 10.1007/s11901-018-0390-1
|
37 |
Aline Almeida Bentes, Roberta Maia De Castro Romanelli, Ana Paula Correa Crispim, Paula Eillanny Silva Marinho, Karina Soares Loutfi, Sara Tavares Araujo, Luciana Maria Campos E Silva, Isabela Guedes, Alice Martins Alvarenga, Marcele Almeida Santos, Erna Geessien Kroon. Neurological manifestations due to dengue virus infection in children: clinical follow-up. Pathogens and Global Health 2021; 115(7-8): 476 doi: 10.1080/20477724.2021.1942680
|
38 |
Jeffrey Rado. Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C. Psychiatric Annals 2017; 47(1): 38 doi: 10.3928/00485713-20161201-01
|
39 |
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Yoshiyuki Sakai, Kyohei Kishino, Naoto Ikeda, Tomoyuki Takashima, Nobuhiro Aizawa, Ryo Takata, Kunihiro Hasegawa, Noriko Ishii, Yukihisa Yuri, Takashi Nishimura, Hiroko Iijima, Shuhei Nishiguchi. Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases. Journal of Clinical Medicine 2018; 8(1): 16 doi: 10.3390/jcm8010016
|
40 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ciro Romano, Aldo Marrone, Raffaele Galiero, Pia Clara Pafundi, Carlo Acierno, Erica Vetrano, Luigi Elio Adinolfi. Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals. Expert Review of Gastroenterology & Hepatology 2021; 15(6): 643 doi: 10.1080/17474124.2021.1877136
|
41 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
|
42 |
Ahmed Esmael, Tamer Belal, Ibrahim F. Amer, Eslam Samra, Azza Elmongui, Saad Shawki. Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2022; 58(1) doi: 10.1186/s41983-022-00450-4
|
43 |
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infection. Medical Council 2020; (21): 248 doi: 10.21518/2079-701X-2019-21-248-253
|
44 |
Jose Martinez-Navio. Neurological complications during HIV infection. Exploration of Neuroprotective Therapy 2021; doi: 10.37349/ent.2021.00004
|
45 |
Matteo Tagliapietra, Salvatore Monaco. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations. International Journal of Molecular Sciences 2020; 21(7): 2478 doi: 10.3390/ijms21072478
|
46 |
Manuel Ramos-Casals, Anna Linda Zignego, Clodoveo Ferri, Pilar Brito-Zerón, Soledad Retamozo, Milvia Casato, Peter Lamprecht, Alessandra Mangia, David Saadoun, Athanasios G. Tzioufas, Zobair M. Younossi, Patrice Cacoub. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. Journal of Hepatology 2017; 66(6): 1282 doi: 10.1016/j.jhep.2017.02.010
|
47 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
|
48 |
Luis Ibáñez‐Samaniego, Marta Rapado‐Castro, Lucia Cabrero, Cristina Navarrete, Seila García‐Mulas, Adriana Ahumada, Laura Marquez, Maria Dolores Pérez, Diego Rincon, Rafael Bañares, Rita Garcia‐Martinez. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real‐life study. European Journal of Neurology 2022; 29(2): 400 doi: 10.1111/ene.15138
|
49 |
Bernhard Scheiner, Philipp Schwabl, Sebastian Steiner, Theresa Bucsics, David Chromy, Maximilian C. Aichelburg, Katharina Grabmeier-Pfistershammer, Michael Trauner, Markus Peck-Radosavljevic, Thomas Reiberger, Mattias Mandorfer. Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease. Medicine 2016; 95(27): e4061 doi: 10.1097/MD.0000000000004061
|
50 |
Alicja K. Popiołek, Margaret A. Niznikiewicz, Alina Borkowska, Maciej K. Bieliński. Evaluation of Event-Related Potentials in Somatic Diseases – Systematic Review. Applied Psychophysiology and Biofeedback 2024; 49(3): 331 doi: 10.1007/s10484-024-09642-5
|
51 |
Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Chiao-Li Khale Ke, Ming-Lung Yu. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open Forum Infectious Diseases 2020; 7(10) doi: 10.1093/ofid/ofaa397
|
52 |
N. Y. Mapoure, M. N. Budzi, S. A. F. B. Eloumou, A. Malongue, C. Okalla, H. N. Luma, Yury E Khudyakov. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLOS ONE 2018; 13(3): e0192406 doi: 10.1371/journal.pone.0192406
|
53 |
Hanaa M. Mohamed, Ayman M. Mahmoud. Chronic exposure to the opioid tramadol induces oxidative damage, inflammation and apoptosis, and alters cerebral monoamine neurotransmitters in rats. Biomedicine & Pharmacotherapy 2019; 110: 239 doi: 10.1016/j.biopha.2018.11.141
|
54 |
Vito Fiore, Valentina Manca, Agnese Colpani, Andrea De Vito, Ivana Maida, Giordano Madeddu, Sergio Babudieri. Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations. Healthcare 2023; 11(14): 2109 doi: 10.3390/healthcare11142109
|
55 |
Xiao-Hong Zhang, Jia-Yan Shi, Chuanyin Zhan, Ling Zhang, Hua-Jun Chen, Marco Aiello. Intrinsic Brain Abnormalities in Patients with Hepatitis C Virus Infection with Cognitive Impairment: A Preliminary Resting-State fMRI Study. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1693043
|
56 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 1671 doi: 10.1007/978-3-319-26956-6_94
|
57 |
Anne Claire Desbois, Patrice Cacoub. Hepatitis C: Care and Treatment. 2021; : 21 doi: 10.1007/978-3-030-67762-6_2
|
58 |
|
59 |
Stefano Fagiuoli, Nicola Caporaso, Filomena Morisco, Fabio Buelli, Giuliana Gualberti, Valeria Saragaglia, Luchino Chessa, Giampaolo Corti, Ivana Maida, Claudio M. Mastroianni, Mario Pirisi, Francesco P. Russo, Francesca Farina, Lydia Giannitrapani, Pierluigi Toniutto, Pierluigi Tarquini, Paolo Tundo, Jacopo Vecchiet, Maria Vinci, Gloria Taliani. HepaDisk – A new quality of life questionnaire for HCV patients. Digestive and Liver Disease 2019; 51(7): 1008 doi: 10.1016/j.dld.2018.12.009
|
60 |
Donna M. Evon, Meichen Dong, Bryce B. Reeve, Joy Peter, Larry Michael, Anna S. Lok, David R. Nelson, Paul W. Stewart. Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial. Journal of Viral Hepatitis 2022; 29(9): 795 doi: 10.1111/jvh.13716
|
61 |
Tatyana Vasiliyevna Polukchi, Gulzhan Narkenovna Abuova, Yelena Alekseevna Slavko. The Neuropsychiatric Aspect of the Chronic Viral Hepatitis. Prague Medical Report 2023; 124(2): 94 doi: 10.14712/23362936.2023.8
|
62 |
Shuchi Pandya, Misbahuddin Syed, Manuel Castro, Jamie P. Morano, Beata Casanas. Global Virology II - HIV and NeuroAIDS. 2017; : 625 doi: 10.1007/978-1-4939-7290-6_24
|
63 |
Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal. Viral Infections of Humans. 2022; : 1 doi: 10.1007/978-1-4939-9544-8_64-1
|
64 |
Regina Juanbeltz, Iván Martínez-Baz, Ramón San Miguel, Silvia Goñi-Esarte, Juan Manuel Cabasés, Jesús Castilla, Yury E. Khudyakov. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients. PLOS ONE 2018; 13(10): e0205277 doi: 10.1371/journal.pone.0205277
|
65 |
Pegah Golabi, Elzafir Elsheikh, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M. Younossi. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV). Medicine 2016; 95(46): e5066 doi: 10.1097/MD.0000000000005066
|
66 |
Jefferson Abrantes, Daniel Simplicio Torres, Carlos Eduardo Brandão – Mello. The Many Difficulties and Subtleties in the Cognitive Assessment of Chronic Hepatitis C Infection. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/9675235
|
67 |
Samuel C. Gable, Maureen K. O’Connor. Caring for Latinxs with Dementia in a Globalized World. 2020; : 69 doi: 10.1007/978-1-0716-0132-7_4
|
68 |
S. Yu. Milovanova, L. V. Lysenko (Kozlovskaya), L. Yu. Milovanova, D. T. Abdurahmanov, M. V. Taranova, A. V. Volkov. Cryoglobulinemic vasculitis associated with HCV infection: still a problem?. Nephrology (Saint-Petersburg) 2022; 26(3): 30 doi: 10.36485/1561-6274-2022-26-3-30-39
|
69 |
Adrienne Studaway, Rohit P. Ojha, Tara M. Brinkman, Nan Zhang, Malek Baassiri, Pia Banerjee, Matthew J. Ehrhardt, Deokumar Srivastava, Leslie L. Robison, Melissa M. Hudson, Kevin R. Krull. Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer. Cancer 2017; 123(22): 4498 doi: 10.1002/cncr.30913
|
70 |
Cassio Santos‐Lima, Breno Souza‐Marques, Flávia Vieira, Maria Isabel Schinoni, Lucas C. Quarantini, Neander Abreu. Neuropsychological effects of direct‐acting antiviral treatment for Hepatitis C virus subjects: A systematic review. Journal of Viral Hepatitis 2021; 28(12): 1672 doi: 10.1111/jvh.13584
|
71 |
Franco Dammacco, Vito Racanelli, Sabino Russi, Domenico Sansonno. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clinical and Experimental Medicine 2016; 16(3): 233 doi: 10.1007/s10238-016-0410-9
|
72 |
Zobair M. Younossi, Maria Stepanova, Jordan Feld, Stefan Zeuzem, Ira Jacobson, Kosh Agarwal, Christophe Hezode, Fatema Nader, Linda Henry, Sharon Hunt. Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial. Journal of Hepatology 2016; 65(1): 33 doi: 10.1016/j.jhep.2016.02.042
|
73 |
Zobair M. Younossi, Aybike Birerdinc, Linda Henry. Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences. Journal of Hepatology 2016; 65(1): S109 doi: 10.1016/j.jhep.2016.07.005
|
74 |
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infection. Nature Reviews Gastroenterology & Hepatology 2018; 15(5): 283 doi: 10.1038/nrgastro.2017.172
|